TNFα induces Ca influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells.

J Exp Clin Cancer Res

State Key Laboratory of Cancer Biology and Experimental Teaching Center of Basic Medicine, Fourth Military Medical University, 169 Changle West Road, Xi'an, 710032, China.

Published: March 2018

AI Article Synopsis

  • TNFα shows promise as an anticancer agent but faces challenges due to systemic toxicity and limited effectiveness at high doses.
  • The study explored how TNFα affects cytosolic calcium levels in HCC cells, finding that increased calcium enhances TNFα’s ability to induce cell apoptosis, both in vitro and in a mouse model.
  • These findings suggest that boosting cytosolic calcium could be a new strategy to improve TNFα’s anti-tumor effects, though further research is needed to identify suitable agents for this approach.

Article Abstract

Background: Tumor necrosis factor-α has been proven an effective anticancer agent in preclinical studies. However, the translation of TNFα from research to clinic has been blocked by significant systemic toxicity and limited efficacy at maximal tolerated dose, which need urgently to be solved.

Methods: The level of cytosolic Ca was assessed by Fura-2 in HCC cells. After changing cytosolic Ca level by using agonists or inhibitors, cell apoptosis was detected by flow cytometry. We also detected the effect of ionomycin or parvalbumin on the anti-tumor activity of TNFα in a mice model. Lastly, we studied the roles of cytosolic Ca in the mitochondrial-dependent intrinsic apoptosis pathway.

Results: Here, we demonstrated that TNFα induced extracellular Ca influx into cytoplasm through transient receptor potential channel in HCC cells. Both cytosolic Ca scavenger and Ca-binding protein PV effectively desensitized hepatocellular carcinoma cells to TNFα, whereas combination ionomycin or 1,4,5-inositol triphosphate significantly sensitized HCC cells to TNFα, indicating that the increased level of cytosolic Ca was positively correlated with the TNFα-induced cell apoptosis in vitro. In a nude mice xenograft model, our data revealed that TNFα combined with ionomycin remarkably synergized the anti-tumor effect of TNFα. Furthermore, we found that TNFα-mediated extracellular Ca influx accelerated TNFα-induced extrinsic apoptosis through activating calpain/IAP/caspase3 pathway.

Conclusions: Our study provides the evidence supporting a novel mechanism by which TNFα induces extracellular Ca influx to enhance cell apoptosis and suggests that increasing the level of cytosolic Ca might be an alternative strategy to improve the pro-apoptotic activity of TNFα in HCC cells, although suitable chemical or biological reagents need to be further tested.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838867PMC
http://dx.doi.org/10.1186/s13046-018-0714-6DOI Listing

Publication Analysis

Top Keywords

hcc cells
16
level cytosolic
12
cell apoptosis
12
extracellular influx
12
tnfα
10
tnfα induces
8
extrinsic apoptosis
8
hepatocellular carcinoma
8
carcinoma cells
8
activity tnfα
8

Similar Publications

Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma.

Hepatology

January 2025

Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, People's Republic of China.

Background And Aims: Immune checkpoint inhibitors (ICIs) have revolutionized systemic hepatocellular carcinoma (HCC) treatment. Nevertheless, numerous patients are refractory to ICIs therapy. It is currently unknown whether diet therapies such as short-term starvation (STS) combined with ICIs can be used to treat HCC.

View Article and Find Full Text PDF

Hepatocellular carcinoma(HCC) has a high mortality and morbidity rate and seriously jeopardizes human life. Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. Therefore, finding novel low-toxicity and high-efficiency anti-hepatocellular carcinoma drugs and exploring their mechanisms of action have become the current problems to be solved in the treatment of HCC.

View Article and Find Full Text PDF

This work researched the influence and mechanism of CD155 on hepatocellular carcinoma advancement. CD155 expression and its effect on survival of hepatocellular carcinoma patients were analyzed based on the GEPIA2 database. String software predicted the interacting between CD155 and CD96, which was further verified by co-immunoprecipitation experiment.

View Article and Find Full Text PDF

Purpose: To investigate the prognostic value of inflammatory indexes based on peripheral blood cells in unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib combined with PD-1 inhibitors.

Methods: This study retrospectively collected baseline inflammatory indexes from HCC patients received Lenvatinib and PD-1 inhibitor-based combination therapy at the Cancer Hospital of the Chinese Academy of Medical Sciences between October 2018 and October 2021. The optimal threshold values for inflammatory indexes determined using X-tile.

View Article and Find Full Text PDF

Background: Sorafenib, an FDA-approved drug for advanced hepatocellular carcinoma (HCC), faces resistance issues, partly due to myeloid-derived suppressor cells (MDSCs) that enhance immunosuppression in the tumor microenvironment (TME).

Methods: Various murine HCC cell lines and MDSCs were used in a series of in vitro and in vivo experiments. These included subcutaneous tumor models, cell viability assays, flow cytometry, immunohistochemistry, and RNA sequencing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!